115 related articles for article (PubMed ID: 8587036)
1. [Kinetic analysis of hepatobiliary transport of drugs: importance of carrier-mediated transport].
Yamazaki M; Nishigaki R; Suzuki H; Sugiyama Y
Yakugaku Zasshi; 1995 Dec; 115(12):953-77. PubMed ID: 8587036
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.
Yamazaki M; Suzuki H; Sugiyama Y
Pharm Res; 1996 Apr; 13(4):497-513. PubMed ID: 8710738
[TBL] [Abstract][Full Text] [Related]
3. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
[TBL] [Abstract][Full Text] [Related]
5. The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance.
Fenner KS; Jones HM; Ullah M; Kempshall S; Dickins M; Lai Y; Morgan P; Barton HA
Xenobiotica; 2012 Jan; 42(1):28-45. PubMed ID: 22077101
[TBL] [Abstract][Full Text] [Related]
6. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045
[TBL] [Abstract][Full Text] [Related]
7. Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver.
Yamazaki M; Suzuki H; Hanano M; Tokui T; Komai T; Sugiyama Y
Am J Physiol; 1993 Jan; 264(1 Pt 1):G36-44. PubMed ID: 8430803
[TBL] [Abstract][Full Text] [Related]
8. Biliary excretion of sulfated bile acids and organic anions in zone 1- and zone 3-injured rats.
Sasamoto T; Sano N; Takikawa H
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):26-31. PubMed ID: 16706808
[TBL] [Abstract][Full Text] [Related]
9. Chronic voluntary exercise may alter hepatobiliary clearance of endogenous and exogenous chemicals in rats.
Watkins JB; Crawford ST; Sanders RA
Drug Metab Dispos; 1994; 22(4):537-43. PubMed ID: 7956727
[TBL] [Abstract][Full Text] [Related]
10. Hepatobiliary transport governs overall elimination of peptidic endothelin antagonists in rats.
Kato Y; Akhteruzzaman S; Hisaka A; Sugiyama Y
J Pharmacol Exp Ther; 1999 Feb; 288(2):568-74. PubMed ID: 9918560
[TBL] [Abstract][Full Text] [Related]
11. Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats.
Yamazaki M; Akiyama S; Nishigaki R; Sugiyama Y
Pharm Res; 1996 Oct; 13(10):1559-64. PubMed ID: 8899851
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.
Lecureux L; Dieter MZ; Nelson DM; Watson L; Wong H; Gemzik B; Klaassen CD; Lehman-McKeeman LD
Toxicol Sci; 2009 Apr; 108(2):482-91. PubMed ID: 19211616
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501
[TBL] [Abstract][Full Text] [Related]
14. Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system.
Nakamura H; Sano H; Yamazaki M; Sugiyama Y
J Pharmacol Exp Ther; 1994 Jun; 269(3):1220-7. PubMed ID: 7912279
[TBL] [Abstract][Full Text] [Related]
15. Membrane transport as a determinant of the hepatic elimination of drugs and metabolites.
Evans AM
Clin Exp Pharmacol Physiol; 1996; 23(10-11):970-4. PubMed ID: 8911743
[TBL] [Abstract][Full Text] [Related]
16. Nonlinear pharmacokinetics of hepatobiliary transport of rose bengal in rats after i.v. bolus administration with varying doses.
Wang HK; Miyachi S; Yamazaki M; Sawada Y; Chung YB; Iga T; Hanano M; Sugiyama Y
Biopharm Drug Dispos; 1992 Dec; 13(9):647-62. PubMed ID: 1467452
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary transport of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors conjugated with bile acids.
Petzinger E; Nickau L; Horz JA; Schulz S; Wess G; Enhsen A; Falk E; Baringhaus KH; Glombik H; Hoffmann A
Hepatology; 1995 Dec; 22(6):1801-11. PubMed ID: 7489992
[TBL] [Abstract][Full Text] [Related]
18. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
[TBL] [Abstract][Full Text] [Related]
19. Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations.
Meijer DK; Mol WE; Müller M; Kurz G
J Pharmacokinet Biopharm; 1990 Feb; 18(1):35-70. PubMed ID: 2184216
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events.
Hatanaka T
Clin Pharmacokinet; 2000 Dec; 39(6):397-412. PubMed ID: 11192473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
